279 related articles for article (PubMed ID: 19468192)
1. Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease.
Kobashi Y; Mouri K; Miyashita N; Oka M
Jpn J Infect Dis; 2009 May; 62(3):239-41. PubMed ID: 19468192
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
4. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
Kawabe Y
Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1422-6. PubMed ID: 19861017
[TBL] [Abstract][Full Text] [Related]
6. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
Respirology; 2009 Mar; 14(2):276-81. PubMed ID: 19210655
[TBL] [Abstract][Full Text] [Related]
8. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
Higuchi K; Okada K; Harada N; Mori T
Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
[TBL] [Abstract][Full Text] [Related]
9. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
[TBL] [Abstract][Full Text] [Related]
10. Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis.
Inui N; Suda T; Chida K
Respir Med; 2008 Feb; 102(2):313-5. PubMed ID: 17980570
[TBL] [Abstract][Full Text] [Related]
11. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.
Arend SM; van Meijgaarden KE; de Boer K; de Palou EC; van Soolingen D; Ottenhoff TH; van Dissel JT
J Infect Dis; 2002 Dec; 186(12):1797-807. PubMed ID: 12447766
[TBL] [Abstract][Full Text] [Related]
12. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(1) tuberculosis outbreak in a Cram School].
Fukazawa K
Kekkaku; 2007 Jan; 82(1):53-9. PubMed ID: 17310782
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Chest; 2008 May; 133(5):1196-202. PubMed ID: 18263689
[TBL] [Abstract][Full Text] [Related]
14. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis.
Dheda K; van Zyl-Smit RN; Meldau R; Meldau S; Symons G; Khalfey H; Govender N; Rosu V; Sechi LA; Maredza A; Semple P; Whitelaw A; Wainwright H; Badri M; Dawson R; Bateman ED; Zumla A
Thorax; 2009 Oct; 64(10):847-53. PubMed ID: 19592392
[TBL] [Abstract][Full Text] [Related]
15. [Outbreak of pulmonary tuberculosis in which tuberculosis developed from QuantiFERON-TB second generation (QFT-2G) test negative persons].
Yamaguchi J; Ooba Y; Kaneda M; Uchida K; Ishikawa Y; Suzuki K; Yagi T; Sasaki Y; Yamagishi F
Kekkaku; 2007 Aug; 82(8):629-34. PubMed ID: 17874570
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB.
Stavri H; Ene L; Popa GL; Duiculescu D; Murgoci G; Marica C; Ulea I; Cus G; Popa MI
Roum Arch Microbiol Immunol; 2009; 68(1):14-9. PubMed ID: 19507622
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a university].
Funayama K; Tsujimoto A; Mori M; Yamamoto H; Fujiwara K; Nishimura T; Hasegawa N; Horiguchi I; Mori T; Marui E
Kekkaku; 2005 Jul; 80(7):527-34. PubMed ID: 16167779
[TBL] [Abstract][Full Text] [Related]
18. ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease.
Fox A; Jeffries DJ; Hill PC; Hammond AS; Lugos MD; Jackson-Sillah D; Donkor SA; Owiafe PK; McAdam KP; Brookes RH
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):691-8. PubMed ID: 17434194
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of QuantiFERON TB-2G test in patients with healed pulmonary tuberculosis.
Kobashi Y; Shimizu H; Mouri K; Obase Y; Miyashita N; Oka M
J Infect Chemother; 2009 Oct; 15(5):288-92. PubMed ID: 19856066
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation on isolation of Mycobacterium kansasii in our hospital].
Inoue T; Tanaka E; Kato T; Sakuramoto M; Maeda Y; Maniwa K; Taguchi Y
Kekkaku; 2004 Jul; 79(7):431-5. PubMed ID: 15354728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
